Product Information
PRAMIPEXOLE 0.125 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0394 per EA under NDC 57237018090. Its NADAC has been published 556 times since Feb 10, 2016.
FDA first approved this application on Oct 26, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.125 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237018090
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PRAMIPEXOLE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202633FDA Approved
10/26/2012
TE Code
AB
On Market Since
10/26/2012
Pharmacological Classes
Price Statistics
The NADAC for PRAMIPEXOLE 0.125 MG TABLET has been published 556 times since Feb 10, 2016, and over the history we have for it it has declined 45.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0394 per EA |
|---|---|
| All-time high | $0.0786 (Jun 15, 2016) |
| All-time low | $0.0350 (Nov 20, 2024) |
| 52-week high | $0.0425 |
| 52-week low | $0.0394 |
| Median price | $0.0515 |
| Average price | $0.0525 |
| Largest weekly change | +23.9% (Jan 20, 2021) |
| Weeks tracked | 556 |
| Tracking since | Feb 10, 2016 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pramipexole Dihydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonergot Dopamine Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PRAMIPEXOLE 0.125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRAMIPEXOLE 0.125 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0394 per EA (NDC 57237018090), effective Sep 30, 2026.
How has the price of PRAMIPEXOLE 0.125 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRAMIPEXOLE 0.125 MG TABLET has declined 45.1%. It has been tracked across 556 weekly CMS publications since Feb 10, 2016.
What are the highest and lowest recorded NADAC prices for PRAMIPEXOLE 0.125 MG TABLET?
Since Feb 10, 2016, the NADAC for PRAMIPEXOLE 0.125 MG TABLET has ranged from a low of $0.0350 (Nov 20, 2024) to a high of $0.0786 (Jun 15, 2016), with a median of $0.0515 per EA.
Are there cheaper alternatives to PRAMIPEXOLE 0.125 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PRAMIPEXOLE 0.125 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PRAMIPEXOLE 0.125 MG TABLET?
PRAMIPEXOLE 0.125 MG TABLET (NDC 57237018090) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.